Tag: Cancer: Prostate
Variable Impact of USPSTF Guidance Against PSA Screen
Differential effect of 2012 USPSTF recommendations for primary care providers, urologists
ASCO Genitourinary Cancers Symposium, Jan. 7-9
The ASCO 2016 Genitourinary Cancers Symposium The annual Genitourinary Cancers Symposium of the American Society of Clinical Oncology was held from Jan. 7...
ASCO: CTC Heterogeneity Predicts Hormone Tx Response in mCRPC
Patients with higher heterogeneity score did not respond well to hormone therapy
ASCO: Aspirin Use Linked to Lower Risk of Lethal Prostate CA
Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis
Diagnostic Factors May Help Patients Avoid Prostate Biopsy
Prostate-specific antigen density, total tumor length are significant predictors
Impact of 2012 USPSTF Guideline Against PSA Screening Explored
After, men undergoing prostate needle biopsy more likely to be diagnosed with high-risk disease
More Adverse Effects for Medical Castration in Prostate Cancer
Higher risks of several clinically relevant adverse effects compared with surgical castration
PSA Screening May Be Harmful for Patients With ESRD
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant
Surgery May Beat Radiotherapy for Localized Prostate Cancer
Analysis of 19 studies suggests surgery has an edge in survival
‘Suicide Gene Therapy’ Plus Radiation Effective in Prostate CA
Immunomodulatory in situ gene tx/IMRT with or without hormonal tx deemed feasible, safe
